Potential and Perspectives of a-CGH Method in Clinical Practice
Abstract
The identification of chromosomal abnormalities is an important component of clinical genetics. Currently, the methods of classical cytogenetics cannot meet the increasing demands of clinical medicine. The development of fluorescence in situ hybridization techniques (FISH, CGH) has made possible the identification of submicroscopic chromosome aberrations. Progress of the technology has led to the emergence of new high-tech method - comparative genomic hybridization on microarrays (array-CGH, a-CGH). This method is used in many areas of clinical genetics, reproductive medicine and oncology. Besides practical applications, a-CGH is used in fundamental medicine, particularly to study the causes of congenital malformations and undifferentiated intellectual disability, as well as fundamental oncology.
About the Authors
N. A. SkryabinRussian Federation
Skryabin Nikolai - PhD, researcher
Tomsk
A. A. Kashevarova
Russian Federation
Kashevarova Anna - PhD, researcher
Tomsk
I. N. Lebedev
Russian Federation
Lebedev Igor - Ph.D., Head. labs.
Tomsk
References
1. Clinical and genetic analysis of idiopathic intellectual disability based on array comparative genomic hybridization / A.A. Kashevarova N.A., Skryabin, A.D.Cheremnykh [et al.] // Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. – 2013. – Vol. 113(9). – P. 70-74.
2. Array-based comparative genomic hybridization (array-CGH) in analysis of chromosomal aberrations and CNV in blighted ovum pregnancies / I.N. Lebedev, A.A. Kashevarova, N.A. Skryabin [et al.] // Zhurnal akusherstva i zhenskih boleznej. – 2013. – V. 62(2). – P. 117-125.
3. Molecular karyotyping (aCGH) as modern approach for investigations of miscarriage causes / T.V. Nikitina, A.A. Kashevarova, N.A. Skryabin [et al.] // Medicinskaja genetika. – 2013. – V. 12. – № 1. – P. 26-35.
4. Array CGH analysis of a cohort of Russian patients with intellectual disability / A.A. Kashevarova, L.P. Nazarenko, N.A. Skryabin [ et al.] // Gene. – 2013. – V. 536(1). – P. 145-150.
5. Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research / R. Hochstenbach, J.E. Buizer-Voskamp, J.A.S. Vorstman [et al.] // Cytogenet Genome Res. – 2011. – Vol. 135. – P. 174-202.
6. Identification of disease genes by whole genome CGH arrays / L. Vissers, J.A. Veltman, A.G. Kessel [et al.] // Human Molecular Genetics. – 2005. – Vol. 14. – P. 215-223.
7. Microdeletion and microduplication syndromes / Weise A., Mrasek K., Klein E. [et al.] // J Histochem Cytochem. – 2012. – Vol. 60(5). – P. 346-358.
8. Shaffer L.G. A cytogeneticist’s perspective on genomic microarrays / L.G, Shaffer, B.A. Bejjani // Human Reproduction Update. – 2004. – Vol.10. – No.3. – P. 221-226.
9. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos / C. GutierrezMateo, P. Colls, J. Sanchez-Garcia [et al.] // Fertil Steril. – 2011. – Vol. 95(3). – P. 953-958.
Review
For citations:
Skryabin N.A., Kashevarova A.A., Lebedev I.N. Potential and Perspectives of a-CGH Method in Clinical Practice. Yakut Medical Journal. 2014;(2):51-52.